Skip to Main content Skip to Navigation
Journal articles

Clinical Utility of a Unique Genome-Wide DNA Methylation Signature for KMT2A-Related Syndrome

Aidin Foroutan 1, 2 Sadegheh Haghshenas 1, 2 Pratibha Bhai 2 Michael A Levy 2 Jennifer Kerkhof 2 Haley Mcconkey 2 Marcello Niceta 3 Andrea Ciolfi 3 Lucia Pedace 3 Evelina Miele 3 David Genevieve 4 Solveig Heide 5 Mariëlle Alders 6, 7 Giuseppe Zampino 8, 9 Giuseppe Merla 10, 11 Mélanie Fradin 12 Eric Bieth 13 Dominique Bonneau 14 Klaus Dieterich 15 Patricia Fergelot 16 Elise Schaefer 17 Laurence Faivre 18, 19 Antonio Vitobello 18, 19 Silvia Maitz 20 Rita Fischetto 21 Cristina Gervasini 22 Maria Piccione 23 Ingrid van de Laar 24 Marco Tartaglia 3 Bekim Sadikovic 1, 2 Anne-Sophie Lebre 25, 26 
Abstract : Wiedemann–Steiner syndrome (WDSTS) is a Mendelian syndromic intellectual disability (ID) condition associated with hypertrichosis cubiti, short stature, and characteristic facies caused by pathogenic variants in the KMT2A gene. Clinical features can be inconclusive in mild and unusual WDSTS presentations with variable ID (mild to severe), facies (typical or not) and other associated malformations (bone, cerebral, renal, cardiac and ophthalmological anomalies). Interpretation and classification of rare KMT2A variants can be challenging. A genome-wide DNA methylation episignature for KMT2A-related syndrome could allow functional classification of variants and provide insights into the pathophysiology of WDSTS. Therefore, we assessed genome-wide DNA methylation profiles in a cohort of 60 patients with clinical diagnosis for WDSTS or Kabuki and identified a unique highly sensitive and specific DNA methylation episignature as a molecular biomarker of WDSTS. WDSTS episignature enabled classification of variants of uncertain significance in the KMT2A gene as well as confirmation of diagnosis in patients with clinical presentation of WDSTS without known genetic variants. The changes in the methylation profile resulting from KMT2A mutations involve global reduction in methylation in various genes, including homeobox gene promoters. These findings provide novel insights into the molecular etiology of WDSTS and explain the broad phenotypic spectrum of the disease.
Complete list of metadata

https://www.hal.inserm.fr/inserm-03561254
Contributor : Clara Martinez Rico Connect in order to contact the contributor
Submitted on : Tuesday, February 8, 2022 - 10:27:01 AM
Last modification on : Friday, September 9, 2022 - 10:20:08 AM
Long-term archiving on: : Monday, May 9, 2022 - 6:29:30 PM

File

Foroutan et al. Int. J. Mol. S...
Publisher files allowed on an open archive

Identifiers

Citation

Aidin Foroutan, Sadegheh Haghshenas, Pratibha Bhai, Michael A Levy, Jennifer Kerkhof, et al.. Clinical Utility of a Unique Genome-Wide DNA Methylation Signature for KMT2A-Related Syndrome. International Journal of Molecular Sciences, MDPI, 2022, 23 (3), pp.1815. ⟨10.3390/ijms23031815⟩. ⟨inserm-03561254⟩

Share

Metrics

Record views

44

Files downloads

36